Medican Director Assumes New Leadership Position as CEO of Cannabis Sativa Inc.
July 07 2014 - 8:00AM
Business Wire
Medican Enterprises, Inc.
(OTCBB:MDCN) a bio-pharmaceutical company focused on developing,
and marketing pharmaceutical grade cannabis to the emerging global
medical marijuana market is pleased to announce its director, Gary
Johnson, was recently appointed CEO of Cannabis Sativa Inc.
(OTCQB:CBDS).
Mr. Johnson, the two-term governor of New Mexico, owned and
operated a construction company that helped build Intel Corp.’s Rio
Rancho, New Mexico, plant before entering politics. He joined the
board of Medican Enterprises Inc. on January 23, 2014.
“I have been a long supporter of medical marijuana and am
committed to furthering the legalization and use of pharmaceutical
grade cannabis,” said Gary Johnson, who has served on the Medican
Board for the past six months. “This new leadership role enables me
to more effectively educate, advocate and promote the great
benefits of medical marijuana. I value my association with industry
leaders like Medican Enterprises and look forward to continuing my
work with them.”
About Medican Enterprises Inc.Medican Enterprises is a
bio-pharmaceutical company focused on developing, distributing and
marketing pharmaceutical grade cannabis to the emerging global
medical marijuana market. It’s wholly owned subsidiary Medican
Systems Inc. is an industry leader in the design, construction and
operation of Medical Marijuana and Cultivation Centers across
Canada. For more information visit: www.medicaninc.com.
Forward-Looking and Cautionary StatementsCertain
statements contained herein contain “forward-looking statements”
within the meaning of Section 27A of Securities Act of 1933, and
Section 21E of the Securities Exchange Act of 1934. Statements in
this press release that are not purely historical are
forward-looking statements and include any statements regarding
beliefs, plans, expectations or intentions regarding the future.
Such forward-looking statements involve known and unknown risks,
uncertainties and other factors, which may cause the actual
results, performance or achievements of Medican Enterprises Inc. to
be materially different from any future results, performance or
achievements expressed or implied by such forward-looking
statements. Given these uncertainties, readers are cautioned not to
place undue reliance on such forward-looking statements. Medican
Enterprises Inc. disclaims any obligation to update or to announce
publicly the results of any revision of the forward-looking
statements contained or incorporated by reference herein to reflect
future events or developments. Although we believe that any
beliefs, plans, expectations and intentions contained in this press
release are reasonable, there can be no assurance that any such
beliefs, plans, expectations or intentions will prove to be
accurate. Investors should consult all of the information set forth
herein and should also refer to the risk factors disclosure
outlined in the reports and other documents we file with the SEC,
available at www.sec.gov.
Medican Enterprises Inc.Ken Williams,
+1-800-416-8802CEOinvestors@medicaninc.com
Medican Enterprises (CE) (USOTC:MDCN)
Historical Stock Chart
From Apr 2024 to May 2024
Medican Enterprises (CE) (USOTC:MDCN)
Historical Stock Chart
From May 2023 to May 2024